Nick Cerrito is the Global Head of the firm’s Life Sciences Practice. His practice focuses on Hatch-Waxman litigation and client counseling in the pharmaceutical industry, with an emphasis on creating strategies at the interface of patent and FDA laws. He has represented large innovator pharmaceutical companies, established biotechnology companies, and start-ups. Mr. Cerrito’s practice also includes, IPR’s/CBM’s, transactional work and due diligence in the areas of pharmaceutical product acquisition, strategic planning, and patent prosecution strategies.
WHAT CLIENTS SAY
"Mr. Cerrito has taken the time to understand our business."
"He's been very effective for us."
MY CLIENT PHILOSOPHY
"When it comes to client service I try to follow 3 important principles. I always make sure I listen to the clients, understand to their business goals, and to be as responsive to their needs as possible."
– F. Dominic Cerrito
ALL-STAR BIOGRAPHY
Nick Cerrito is the Global Head of the firm’s Life Sciences Practice. His practice focuses on Hatch-Waxman litigation and client counseling in the pharmaceutical industry, with an emphasis on creating strategies at the interface of patent and FDA laws. He has represented large innovator pharmaceutical companies, established biotechnology companies, and start-ups. Mr. Cerrito’s practice also includes, IPR’s/CBM’s, transactional work and due diligence in the areas of pharmaceutical product acquisition, strategic planning, and patent prosecution strategies.
ALL-STAR BIOGRAPHY
Nick Cerrito is the Global Head of the firm’s Life Sciences Practice. His practice focuses on Hatch-Waxman litigation and client counseling in the pharmaceutical industry, with an emphasis on creating strategies at the interface of patent and FDA laws. He has represented large innovator pharmaceutical companies, established biotechnology companies, and start-ups. Mr. Cerrito’s practice also includes, IPR’s/CBM’s, transactional work and due diligence in the areas of pharmaceutical product acquisition, strategic planning, and patent prosecution strategies.